PTC Therapeutics, Inc. (NASDAQ:PTCT) Q2 2023 Earnings Call Transcript August 4, 2023 Operator: Good day, and thank you for standing by and welcome to the PTC Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] […]
Endurant Capital Management LP purchased a new stake in shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Rating) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 17,886 shares of the biopharmaceutical company’s stock, valued at approximately $683,000. Other hedge funds have also added to […]
PTC Therapeutics (NASDAQ:PTCT – Get Rating) had its target price lifted by The Goldman Sachs Group from $35.00 to $37.00 in a report issued on Wednesday morning, The Fly reports. A number of other equities research analysts have also recently commented on the stock. Citigroup raised their price target on shares of PTC Therapeutics from […]
Operator: Good day, and thank you for standing by and welcome to the PTC First Quarter 2023 Financial Results Call. All participants are in a listen-only mode.
Operator: Good day, and welcome to the PTC Therapeutics Fourth Quarter 2022 Corporate Update and Financial Results Call. At this time, all participants are in a listen-only mode.